Impact of primary organ site of involvement by peripheral T‐cell lymphoma not otherwise specified on survival
Abstract Introduction Peripheral T‐cell lymphoma, not otherwise specified (PTCL‐NOS) is a rare, highly heterogeneous group of mature T‐cell neoplasms that historically has been associated with poor outcomes. We sought to investigate the influence of primary disease site on PTCL‐NOS outcomes using a...
Main Authors: | Olivia Davis, Derek Truong, Silas Day, Manu Pandey, Sami Ibrahimi, Mohamad Khawandanah, Jennifer Holter‐Chakrabarty, Adam Asch, Taha Al‐Juhaishi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-12-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.6743 |
Similar Items
-
Pralatrexate for Prolonged Treatment of Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified, with Prophylactic Leucovorin
by: Koichi Kitazume, et al.
Published: (2019-07-01) -
Clinico-Epidemiological Presentation and Treatment Outcome of Peripheral T-Cell Lymphoma– Not Otherwise Specified (PTCL-NOS): A Single Institutional Experience
by: Partha Sarathi Roy, et al.
Published: (2023-08-01) -
A case report of double positive peripheral T cell lymphoma- not otherwise specified in a young pregnant female
by: Nishi Trivedi, et al.
Published: (2022-01-01) -
Aggressive CD4–CD8–CD45RA+CCR10– Primary Cutaneous Peripheral T-cell Lymphoma, Not Otherwise Specified: A Case Report
by: Natsumi Ikumi, et al.
Published: (2019-09-01) -
The role of pre-treatment and mid-treatment 18F-FDG PET/CT imaging in evaluating prognosis of peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS)
by: Yafei Zhang, et al.
Published: (2021-10-01)